EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis

Zhe Zhang, Xiaoli Shen, Zilong Tan, Yuran Mei, Tianzhu Lu, Yulong Ji, Sida Cheng, Yu Xu, Zekun Wang, Xinxian Liu, Wei He, Zhen Chen und 2 weitere

Frontiers in Genetics · 13.01.2023 · 13

DOI: 10.3389/fgene.2022.1053263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 13.01.2023. Verfasst von Zhe Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioma is the most common primary tumor of the central nervous system. The conventional glioma treatment strategies include surgical excision and chemo- and radiation-therapy. Interferon Gamma (IFN-γ) is a soluble dimer cytokine involved in immune escape of gliomas. In this study, we sought to identify IFN-γ-related genes to construct a glioma prognostic model to guide its clinical treatment.

Methods

RNA sequences and clinicopathological data were downloaded from The Cancer Genome Atlas (TCGA) and the China Glioma Genome Atlas (CGGA). Using univariate Cox analysis and the Least Absolute Shrinkage and Selection Operator (LASSO) regression algorithm, IFN-γ-related prognostic genes were selected to construct a risk scoring model, and analyze its correlation with the clinical features. A high-precision nomogram was drawn to predict prognosis, and its performance was evaluated using calibration curve. Finally, immune cell infiltration and immune checkpoint molecule expression were analyzed to explore the tumor microenvironment characteristics associated with the risk scoring model.

Results

Four out of 198 IFN-γ-related genes were selected to construct a risk score model with good predictive performance. The expression of four IFN-γ-related genes in glioma tissues was significantly increased compared to normal brain tissue ( p < 0.001). Based on ROC analysis, the risk score model accurately predicted the overall survival rate of glioma patients at 1 year (AUC: The Cancer Genome Atlas 0.89, CGGA 0.59), 3 years (AUC: TCGA 0.89, CGGA 0.68), and 5 years (AUC: TCGA 0.88, CGGA 0.70). Kaplan-Meier analysis showed that the overall survival rate of the high-risk group was significantly lower than that of the low-risk group ( p < 0.0001). Moreover, high-risk scores were associated with wild-type IDH1 , wild-type ATRX , and 1P/19Q non-co-deletion. The nomogram predicted the survival rate of glioma patients based on the risk score and multiple clinicopathological factors such as age, sex, pathological grade, and IDH Status, among others. Risk score and infiltrating immune cells including CD8 T-cell, resting CD4 memory T-cell, regulatory T-cell (Tregs), M2 macrophages, resting NK cells, activated mast cells, and neutrophils were positively correlated ( p < 0.05). In addition, risk scores closely associated with expression of immune checkpoint molecules such as PD-1, PD-L1, CTLA-4, LAG-3, TIM-3, TIGIT, CD48, CD226, and CD96.

Conclusion

Our risk score model reveals that IFN-γ -associated genes are an independent prognostic factor for predicting overall survival in glioma, which is closely associated with immune cell infiltration and immune checkpoint molecule expression. This model will be helpful in predicting the effectiveness of immunotherapy and survival rate in patients with glioma.

Schlagwörter

Stichwörter der Autor:innen

gliomaimmune signatureinterferon gammaprognosistumor microenvironment

Autor:innen und Institutionen

  • Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Jiangxi Key Laboratory of Translational Cancer Research, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China.
  • Department of Radiation Oncology and Head and Neck Surgery, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China.
  • Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, Jiangxi, China.

Zitieren

APA

Zhang, Z., Shen, X., Tan, Z., Mei, Y., Lu, T., Ji, Y., Cheng, S., Xu, Y., Wang, Z., Liu, X., He, W., Chen, Z., Chen, S., & Lv, Q. (2023). Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis. Frontiers in Genetics, 13. https://doi.org/10.3389/fgene.2022.1053263

Vancouver

Zhang Z, Shen X, Tan Z, Mei Y, Lu T, Ji Y, et al. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis. Frontiers in Genetics. 2023;13. doi:10.3389/fgene.2022.1053263

BibTeX
@article{Zhang2023,
  author = {Zhang, Zhe and Shen, Xiaoli and Tan, Zilong and Mei, Yuran and Lu, Tianzhu and Ji, Yulong and Cheng, Sida and Xu, Yu and Wang, Zekun and Liu, Xinxian and He, Wei and Chen, Zhen and Chen, Shuhui and Lv, Qiaoli},
  title = {Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis},
  journal = {Frontiers in Genetics},
  year = {2023},
  volume = {13},
  doi = {10.3389/fgene.2022.1053263}
}
Kostenlos starten →